首页> 外文期刊>Medical dosimetry: official journal of the American Association of Medical Dosimetrists >Postmastectomy radiotherapy with integrated scar boost using helical tomotherapy
【24h】

Postmastectomy radiotherapy with integrated scar boost using helical tomotherapy

机译:乳腺切除术后放射疗法结合螺旋体层断层摄影术增加疤痕

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to evaluate helical tomotherapy dosimetry in postmastectomy patients undergoing treatment for chest wall and positive nodal regions with simultaneous integrated boost (SIB) in the scar region using strip bolus. Six postmastectomy patients were scanned with a 5-mm-thick strip bolus covering the scar planning target volume (PTV) plus 2-cm margin. For all 6 cases, the chest wall received a total cumulative dose of 49.3-50.4 Gy with daily fraction size of 1.7-2.0 Gy. Total dose to the scar PTV was prescribed to 58.0-60.2 Gy at 2.0-2.5 Gy per fraction. The supraclavicular PTV and mammary nodal PTV received 1.7-1.9 dose per fraction. Two plans (with and without bolus) were generated for all 6 cases. To generate no-bolus plans, strip bolus was contoured and overrode to air density before planning. The setup reproducibility and delivered dose accuracy were evaluated for all 6 cases. Dose-volume histograms were used to evaluate dose-volume coverage of targets and critical structures. We observed reduced air cavities with the strip bolus setup compared with what we normally see with the full bolus. The thermoluminescence dosimeters (TLD) in vivo dosimetry confirmed accurate dose delivery beneath the bolus. The verification plans performed on the first day megavoltage computed tomography (MVCT) image verified that the daily setup and overall dose delivery was within 2% accuracy compared with the planned dose. The hotspot of the scar PTV in no-bolus plans was 111.4% of the prescribed dose averaged over 6 cases compared with 106.6% with strip bolus. With a strip bolus only covering the postmastectomy scar region, we observed increased dose uniformity to the scar PTV, higher setup reproducibility, and accurate dose delivered beneath the bolus. This study demonstrates the feasibility of using a strip bolus over the scar using tomotherapy for SIB dosimetry in postmastectomy treatments.
机译:这项研究的目的是评估接受乳房条带切除术同时治疗胸部壁和淋巴结阳性区域并同时在疤痕区域同时增强(SIB)的乳房切除术后患者的螺旋体层摄影剂量。六名乳房切除术后的患者接受了5毫米厚的带状弹丸扫描,覆盖了疤痕计划目标体积(PTV)加2厘米边缘。对于所有6例患者,胸壁接受的总累积剂量为49.3-50.4 Gy,日剂量为1.7-2.0 Gy。疤痕PTV的总剂量规定为每份2.0-2.5 Gy的58.0-60.2 Gy。锁骨上PTV和乳腺淋巴结PTV每部分接受1.7-1.9剂量。对于所有6例病例,均生成了两个计划(带或不带推注)。为了生成无推注计划,先对带状推注进行轮廓处理,然后在计划之前覆盖空气密度。对所有6例患者均评估了设置的可重复性和所提供的剂量准确性。剂量-体积直方图用于评估目标和关键结构的剂量-体积覆盖率。与通常的全剂量推注相比,我们观察到了带状推注设置减少了气腔。体内剂量测定的热致发光剂量计(TLD)确认了大剂量下的准确剂量输送。在第一天的兆伏计算机断层扫描(MVCT)图像上执行的验证计划验证,与计划的剂量相比,每日设置和总剂量输送的精度在2%以内。在无推注计划中,疤痕PTV的热点是6例患者的平均处方剂量的111.4%,而带推注治疗的热点为106.6%。使用仅覆盖乳房切除术后疤痕区域的剥离推注,我们观察到疤痕PTV的剂量均匀性提高,设置重现性更高,并且推注下方的剂量准确。这项研究表明,在乳房切除术后的治疗中,使用X线断层摄影术在SIB剂量测定中使用条形推注治疗疤痕的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号